Analysis of AstraZeneca's market potential, including China and IRA impacts, and the importance of key readouts in 2025 for ...

If you suffered losses exceeding $100,000 in AstraZeneca between between February 23, 2022 and December 17, 2024 and would ...

AstraZeneca PLC AZN shares inched down 0.34% to £105.94 Friday, on what proved to be an all-around poor trading session for ...

Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both ...

The AstraZeneca PLC ADR AZN inched 0.56% higher to $66.25 Friday, on what proved to be an all-around great trading session ...

Volrustomig is under clinical development by AstraZeneca and currently in Phase II for Malignant Neoplasms. According to GlobalData, Phase II drugs for Malignant Neoplasms does not have sufficient ...

Finally, the AstraZeneca class action lawsuit alleges that on December 18, 2024, Financial Times published an article ...

AZD-0780 is under clinical development by AstraZeneca and currently in Phase I for Renal Failure. According to GlobalData, Phase I drugs for Renal Failure have a 74% phase transition success rate ...

IT worker can continue legal battle against pharmaceutical giant after judge rules that impact of skin condition makes him a ...

LCH Health and Community Services has been awarded a second-year grant from the AstraZeneca Foundation’s Creating Health ...

We recently compiled a list of the U.K. Dividend Champions List: 2024 Rankings by Yield. In this article, we are going to ...

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased AstraZeneca PLC (“AstraZeneca ...